Phillip Monk | CSO
Synairgen Research Ltd
Appearances:
WVIC/WAC Day 2 - Nov 30 @ 15:30
Inhaled Interferon-beta (SNG001) for the treatment of COVID-19 and other severe viral lung infections
last published: 01/Dec/22 17:25 GMT
For conference programme and speaking opportunities:
Lauren Sheppard
lauren.sheppard@terrapinn.com
For sponsorship and exhibition opportunities:
Thomas Hall
thomas.hall@terrapinn.com
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events